Form D · Biotechnology
Travera, Inc.
Medford, MA · CIK 0001732756
Offering snapshot reported Jul 14, 2021 · SEC filing
- Reported sold
- $4M Offering amount: $4M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 14, 2021 | Initial | $4,000,000 | No comparison | Not reported | SEC filing |
| Apr 20, 2021 | Amendment | $8,409,856 | $3,834,856vs Jun 19, 2018 | 20 | SEC filing |
| Jul 8, 2019 | Amendment | $6,709,856 | $2,134,856vs Jun 19, 2018 | 18 | SEC filing |
| Jun 19, 2018 | Initial | $4,575,000 | No comparison | 17 | SEC filing |
| Feb 26, 2018 | Initial | $850,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-406186
Source: Form D, filed Jul 14, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| L. Robert Johnson | Director |
| L. Robert Johnson | Director |
| Laurence Robert Johnson | Director |
| David Margulies | Director |
| Clifford A. Reid | Director, Executive |
| Patrick Zhang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
200 Boston Avenue Suite 1500
Medford, MA, 02155
Medford, MA, 02155